154 related articles for article (PubMed ID: 38633112)
1. Type II mast cells in mast cell leukemia: Uncommon yet clinically significant.
Chen CP; Chen D
EJHaem; 2024 Apr; 5(2):412-413. PubMed ID: 38633112
[No Abstract] [Full Text] [Related]
2. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
[TBL] [Abstract][Full Text] [Related]
3. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the understanding and therapeutic management of mastocytosis.
Rossignol J; Polivka L; Maouche-Chrétien L; Frenzel L; Dubreuil P; Hermine O
F1000Res; 2019; 8():. PubMed ID: 31824655
[TBL] [Abstract][Full Text] [Related]
5. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation.
Chen TY; Chen JS; Huang WT; Su WC; Tsao CJ
Bone Marrow Transplant; 2003 Jul; 32(1):111-4. PubMed ID: 12815487
[TBL] [Abstract][Full Text] [Related]
6. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
Chantorn R; Shwayder T
Pediatr Dermatol; 2012; 29(5):605-9. PubMed ID: 22329485
[TBL] [Abstract][Full Text] [Related]
7. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
8. Mast cell leukemia? Malignant mastocytosis with leukemia-like manifestations.
EFRATI P; KLAJMAN A; SPITZ H
Blood; 1957 Oct; 12(10):869-82. PubMed ID: 13471655
[No Abstract] [Full Text] [Related]
9. Mast cell leukemia.
Georgin-Lavialle S; Lhermitte L; Dubreuil P; Chandesris MO; Hermine O; Damaj G
Blood; 2013 Feb; 121(8):1285-95. PubMed ID: 23243287
[TBL] [Abstract][Full Text] [Related]
10. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
11. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
12. Regulation of normal and neoplastic human mast cell development in mastocytosis.
Metcalfe DD
Trans Am Clin Climatol Assoc; 2005; 116():185-203; discussion 203-4. PubMed ID: 16555614
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow findings in systemic mastocytosis.
Horny HP; Parwaresch MR; Lennert K
Hum Pathol; 1985 Aug; 16(8):808-14. PubMed ID: 3860469
[TBL] [Abstract][Full Text] [Related]
14. A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation.
Bae MH; Kim HK; Park CJ; Seo EJ; Park SH; Cho YU; Jang S; Chi HS; Lee KH
Ann Lab Med; 2013 Mar; 33(2):125-9. PubMed ID: 23483057
[TBL] [Abstract][Full Text] [Related]
15. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
Pardanani A; Tefferi A; Al-Kali A; Patnaik M; Hogan WJ; Begna K; Elliott MA; Khera N; Palmer JM; Gangat N; Orazi A; Kelemen K; Reichard KK; Chen D
Am J Hematol; 2024 Jan; 99(1):E1-E4. PubMed ID: 37688525
[TBL] [Abstract][Full Text] [Related]
17. The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis.
Haenisch B; Herms S; Molderings GJ
Immunol Res; 2013 May; 56(1):155-62. PubMed ID: 23504229
[TBL] [Abstract][Full Text] [Related]
18. [Mast cell leukemia--case report].
Vasilj A; Katović SK; Maricević I; Zokvić E; Gaćina P
Acta Med Croatica; 2013 Mar; 67(1):61-4. PubMed ID: 24279257
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.
Sotlar K; Cerny-Reiterer S; Petat-Dutter K; Hessel H; Berezowska S; Müllauer L; Valent P; Horny HP
Mod Pathol; 2011 Apr; 24(4):585-95. PubMed ID: 21186345
[TBL] [Abstract][Full Text] [Related]
20. The international consensus classification of mastocytosis and related entities.
Leguit RJ; Wang SA; George TI; Tzankov A; Orazi A
Virchows Arch; 2023 Jan; 482(1):99-112. PubMed ID: 36214901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
